HOLBROOK, N.Y., Dec. 6, 2012 /PRNewswire/ -- Northstar Global Business Services, Inc. Symbol (OTCPink: MDIN), today announced plans to release "StemEnrich© For pets", the first stem cell replacement therapy product made specifically for house pets. The new product is a welcomed addition to the company's existing product line which includes the popular products, "Snorenz®", and "Good Night's Sleep®", both of which have been very successful, selling millions of units annually in past years. These products have been on the shelves of large retail chains like Wal-Mart®, Walgreens® and CVS®, and after a two-year break, have already begun shipping to retailers once again with the goal of being distributed through every major retail chain in the US.

We all know pet owners will do and spend just about anything for their pets. Even through a recession, the pet food, food supplement and pet health products industries have grown 6-7% every year reaching over a half trillion dollars annually. Like StemIntense©, another Northstar Product which starts shipping in just a few weeks, StemEnrich© uses special extracts from all natural aquatic algae to increase free flowing adult stem cells in the body of both humans and animals. With vitamins and nutrients specific to domestic dogs and cats added, StemEnrich© can increase the length and quality of life of pets substantially. Independent studies show that these compounds increase muscle and bone strength, decrease the chances of injuries, kill pain, increase eyesight and hearing performance, and give animals more endurance. It's also been shown to increase memory and create an overall happier and clearer mental state according to laboratory tests.

Packaged as a one-a-day treat, StemEnrich will also speed up recovery and healing of injuries, a factor very important since our pets cannot tell us what ails them. "If I knew that giving my dog a small treat every day would make her live longer, and be more comfortable, I would have been making this product years ago. It's especially important for rare breeds who typically have many ailments as a result of genetics," said Nicholas Chieco, Northstar's CEO. "This is basically a one size fits all cure for pets, and I am really proud to think we may help millions of pets live happier lives. It makes you feel really good about what you are doing," he added.

The company plans to release StemEnrich© later in the year through already existing retail channels, most of which have pet sections, making distribution an extension of what the company is already doing, not an entirely new venture. The product will retail for about $9.99 for a 30-day supply and earns the company an estimated $4.25 per unit. The biggest challenge the company faces is manufacturing enough products for the current demand, a problem CEO Nick Chieco is happy to have. Initial projections based on current interest have 2013 projected sales at well over two million units right now, but according to Chieco that number will likely go up, and possibly even surpass the company's other products in sales revenue within three years. Northstar aims to be a major leader in alternative health products, and at their current rate as long as they can line up the manufacturing to fulfill orders, there seems to be no ceiling on the potential earnings for the company's next fiscal year, and no stopping Northstar from supplying alternative health products and supplements to every major retail chain in the world.

About Northstar

Northstar Global Business Services is a business services company with a division called "MedGen Healthcare Products", dedicated to producing alternative healthcare products. The most popular products in Northstar's arsenal are Snorenz©, and "Good Night's Sleep", an FDA approved sleep aid. Some products use the company's patented spray delivery system, have received very positive consumer reviews all over the world, and sold million upon millions of units from 1996 to the present.

DISCLAIMER

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

Contact Northstar Global Business Services at (877) 571-4387 ext. 4

SOURCE Northstar Global Business Services, Inc.